42,756 RSUs granted to interim CEO at American Healthcare REIT (NYSE: AHR)

Rhea-AI Filing Summary

American Healthcare REIT, Inc. granted Interim CEO and President Jeffrey T. Hanson 42,756 time-based restricted stock units on March 26, 2026. Each RSU converts into one share of common stock, giving him 42,756 common shares subject to vesting conditions.

The RSUs vest on the earlier of March 15, 2027, or within 30 days after his service ends as Interim CEO. If his interim role ends before December 31, 2026, he receives a pro-rated portion of the grant’s value based on time served in 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hanson Jeffrey T

Role Interim CEO and President

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	42,756	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 42,756 shares (Direct)

Footnotes (1)

1. Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock. On March 26, 2026, the Issuer awarded the Reporting Person 42,756 time-based RSUs. The RSUs vest on the earlier of (1) March 15, 2027 and (2) within 30 days following his termination as Interim Chief Executive Officer and President of the Issuer ("Interim CEO"). If the Reporting Person's service as Interim CEO ends prior to December 31, 2026, he will receive a pro-rated portion of the grant date value of the RSUs based on the portion of the 2026 calendar year during which he served as Interim CEO.

Key Figures

RSUs granted: 42,756 RSUs RSUs to shares ratio: 1 RSU : 1 share Post-grant RSU holdings: 42,756 units +2 more

5 metrics

RSUs granted 42,756 RSUs Grant to Interim CEO on March 26, 2026

RSUs to shares ratio 1 RSU : 1 share Each RSU converts into one share of common stock

Post-grant RSU holdings 42,756 units Total restricted stock units following the transaction

Primary vesting date March 15, 2027 Earlier vesting trigger alongside 30 days after interim role ends

Pro‑ration cutoff date December 31, 2026 Pro-rated value if interim service ends before this date

Key Terms

Restricted Stock Unit, time-based RSUs, vest, Interim Chief Executive Officer

4 terms

Restricted Stock Unit financial

"Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

time-based RSUs financial

"the Issuer awarded the Reporting Person 42,756 time-based RSUs."

vest financial

"The RSUs vest on the earlier of (1) March 15, 2027 and (2) within 30 days"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Interim Chief Executive Officer financial

"following his termination as Interim Chief Executive Officer and President of the Issuer"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hanson Jeffrey T

(Last) (First) (Middle)

18191 VON KARMAN AVE

SUITE 300

(Street)

IRVINE CALIFORNIA 92612

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CEO and President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	03/26/2026		A		42,756		(2)	(2)	Common Stock	42,756	$0	42,756	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock.

2. On March 26, 2026, the Issuer awarded the Reporting Person 42,756 time-based RSUs. The RSUs vest on the earlier of (1) March 15, 2027 and (2) within 30 days following his termination as Interim Chief Executive Officer and President of the Issuer ("Interim CEO"). If the Reporting Person's service as Interim CEO ends prior to December 31, 2026, he will receive a pro-rated portion of the grant date value of the RSUs based on the portion of the 2026 calendar year during which he served as Interim CEO.

	/s/ JEFFREY T. HANSON	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did American Healthcare REIT (AHR) disclose in this Form 4?

American Healthcare REIT disclosed a grant of 42,756 time-based restricted stock units to Interim CEO and President Jeffrey T. Hanson, which convert into common shares subject to specific vesting and service-based conditions tied to his interim leadership role.

How many RSUs did AHR grant to Interim CEO Jeffrey T. Hanson?

AHR granted 42,756 time-based restricted stock units to Interim CEO Jeffrey T. Hanson. Each RSU converts into one share of common stock, so the grant represents 42,756 potential shares, contingent on future vesting and continued service in his interim position.

When do Jeffrey T. Hanson’s RSUs at American Healthcare REIT vest?

The RSUs vest on the earlier of March 15, 2027, or within 30 days after Hanson’s service ends as Interim CEO. This structure links vesting to both a fixed future date and the timing of his interim leadership transition at the company.

What happens to AHR RSUs if the Interim CEO role ends before December 31, 2026?

If Hanson’s service as Interim CEO ends before December 31, 2026, he receives a pro-rated portion of the RSU grant’s value. The pro-ration is based on the portion of the 2026 calendar year during which he served in the interim chief executive role.

Does the AHR RSU grant involve an open-market stock purchase or sale?

No, this RSU grant is a compensation-related award, not an open-market stock purchase or sale. The 42,756 RSUs were awarded at zero price per unit and will convert into common shares only if the vesting and service conditions are satisfied over time.